Max Healthcare Institute Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹604.85
- Today's High:
- ₹625.05
- Open Price:
- ₹625
- 52W Low:
- ₹380.5
- 52W High:
- ₹630
- Prev. Close:
- ₹620.75
- Volume:
- 38218
Company Statistics
- Market Cap.:
- ₹558.82 billion
- Book Value:
- 76.187
- Revenue TTM:
- ₹47.81 billion
- Operating Margin TTM:
- 22.63%
- Gross Profit TTM:
- ₹29.70 billion
- Profit Margin:
- 24.49%
- Return on Assets TTM:
- 6.53%
- Return on Equity TTM:
- 16.12%
Company Profile
Max Healthcare Institute Limited had its IPO on under the ticker symbol MAXHEALTH.
The company operates in the Healthcare sector and Medical Care Facilities industry. Max Healthcare Institute Limited has a staff strength of 0 employees.
Stock update
Shares of Max Healthcare Institute Limited opened at ₹625 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹604.85 - ₹625.05, and closed at ₹618.2.
This is a -0.41% slip from the previous day's closing price.
A total volume of 38,218 shares were traded at the close of the day’s session.
In the last one week, shares of Max Healthcare Institute Limited have increased by +7.79%.
Max Healthcare Institute Limited's Key Ratios
Max Healthcare Institute Limited has a market cap of ₹558.82 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Max Healthcare Institute Limited’s revenue was ₹47.81 billion with a gross profit of ₹29.70 billion and an EBITDA of ₹12.92 billion. The EBITDA ratio measures Max Healthcare Institute Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Max Healthcare Institute Limited’s operating margin was 22.63% while its return on assets stood at 6.53% with a return of equity of 16.12%.
In Q2, Max Healthcare Institute Limited’s quarterly earnings growth was a positive 38.2% while revenue growth was a positive 20.5%.
Max Healthcare Institute Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 47.7386
- PEG
Its diluted EPS in the last 12-months stands at ₹12.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Max Healthcare Institute Limited’s profitability.
Max Healthcare Institute Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Max Healthcare Institute Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹101.02 billion
- Total Liabilities
- ₹10.46 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Max Healthcare Institute Limited ended 2024 with ₹101.02 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹101.02 billion while shareholder equity stood at ₹74.10 billion.
Max Healthcare Institute Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹10.46 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹24.55 billion in goodwill. Its cash balance stood at ₹427.50 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹4.97 billion.
Max Healthcare Institute Limited’s total current assets stands at ₹19.43 billion while long-term investments were ₹0 and short-term investments were ₹14.56 billion. Its net receivables were ₹3.36 billion compared to accounts payable of ₹5.43 billion and inventory worth ₹762.30 million.
In 2024, Max Healthcare Institute Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Max Healthcare Institute Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹618.2
- 52-Week High
- ₹630
- 52-Week Low
- ₹380.5
- Analyst Target Price
- ₹
Max Healthcare Institute Limited stock is currently trading at ₹618.2 per share. It touched a 52-week high of ₹630 and a 52-week low of ₹630. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹582.4 and 200-day moving average was ₹500.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 2406.3% of the company’s stock are held by insiders while 5384.9% are held by institutions.
Frequently Asked Questions About Max Healthcare Institute Limited
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of 17 healthcare facilities, including eight hospitals and four medical centres in Delhi and National Capital Region region, with the remaining located at Mumbai in Maharashtra; Mohali and Bathinda in Punjab; and Dehradun in Uttrakhand. The company is based in Gurugram, India.